Clinical Trials Browser

Phase 2 × fluzoparib × Gastrointestinal × Clear all

NCT06516445 2024-07-24

SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06055166 2023-09-26

A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma